| |
Article Title |
Author(s) |
Type (Status) |
Available Online |
|
Adjuvant Interferon Therapy for Patients at High Risk for Recurrent Melanoma: An Updated Systematic Review and Practice Guideline
DOI: 10.1016/j.clon.2011.12.002
Abstract: After complete resection of melanoma, some patients remain at high risk for recurrence. The efficacy of adjuvant systemic therapy has been inconsistent in randomised trials and remains contr...
|
T. Petrella,
S. Verma,
K. Spithoff,
I. Quirt,
D. McCready,
the Melanoma Disease Site Group
et al.
|
Full-length article
(In Press Corrected Proof)
|
16 January 2012 |
|
Intra-fraction Motion during Extreme Hypofractionated Radiotherapy of the Prostate using Pre- and Post-treatment Imaging
DOI: 10.1016/j.clon.2011.12.001
Abstract: Aims: To determine intra-fraction displacement of the prostate during extreme hypofractionated radiotherapy using pre- and post-treatment orthogonal images with three implanted gold seed fid...
|
H. Quon,
D.A. Loblaw,
P.C.F. Cheung,
L. Holden,
C. Tang,
G. Pang,
G. Morton,
A. Mamedov,
A. Deabreu
et al.
|
Full-length article
(In Press Corrected Proof)
|
09 January 2012 |
|
Radionuclide Therapy in Neuroendocrine Tumours: A Systematic Review
DOI: 10.1016/j.clon.2011.12.003
Abstract: The purpose of this systematic review was to investigate the effects of therapeutic radiopharmaceuticals in patients with different types of advanced neuroendocrine tumour (NETs). A literatu...
|
K.Y. Gulenchyn,
X. Yao,
S.L. Asa,
S. Singh,
C. Law
et al.
|
Full-length article
(In Press Corrected Proof)
|
06 January 2012 |
|
Long-term Outcomes and Prognostic Factors of Re-irradiation for Locally Recurrent Nasopharyngeal Carcinoma using Intensity-modulated Radiotherapy
DOI: 10.1016/j.clon.2011.11.010
Abstract: Aims: To analyse the outcomes and to evaluate the prognostic factors involved in the re-irradiation of locally recurrent nasopharyngeal carcinoma (NPC) using intensity-modulated radiotherapy...
|
Fei Han,
Chong Zhao,
Shao-Min Huang,
Li-Xia Lu,
Ying Huang,
Xiao-Wu Deng,
Wei-Yuan Mai,
Bin S. Teh,
E. Brian Butler,
Tai-Xiang Lu
et al.
|
Full-length article
(In Press Corrected Proof)
|
03 January 2012 |
|
Adaptive Radiotherapy Using Helical Tomotherapy for Head and Neck Cancer in Definitive and Postoperative Settings: Initial Results
DOI: 10.1016/j.clon.2011.11.005
Abstract: Aims: To assess whether routine mid-treatment replanning in head and neck squamous cell carcinoma patients results in meaningful improvements in target or normal tissue dosimetry and to asse...
|
L. Capelle,
M. Mackenzie,
C. Field,
M. Parliament,
S. Ghosh,
R. Scrimger
et al.
|
Full-length article
(In Press Corrected Proof)
|
26 December 2011 |
|
Evidence-based Guideline Recommendations on the use of Positron Emission Tomography Imaging in Colorectal Cancer
DOI: 10.1016/j.clon.2011.11.008
Abstract: Aims: To provide evidence-based practice guideline recommendations on the use of fluoro-2-deoxy-d-glucose positron emission tomography (PET) for diagnosis, staging, assessing treatment respo...
|
K. Chan,
S. Welch,
C. Walker-Dilks,
A. Raifu
|
Short communication
(In Press Corrected Proof)
|
23 December 2011 |
|
18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Assessment of Occult Primary Head and Neck Cancers — An Audit and Review of Published Studies
DOI: 10.1016/j.clon.2011.11.001
Abstract: Aims: To assess the value of 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in patients with squamous cell and undifferentiated cancer neck nodes and ...
|
W.L. Wong,
L.I. Sonoda,
A. Gharpurhy,
F. Gollub,
D. Wellsted,
K. Goodchild,
C. Lemon,
R. Farrell,
M. Saunders
et al.
|
Full-length article
(In Press Corrected Proof)
|
19 December 2011 |
|
Anatomical and Dose Changes of Gross Tumour Volume and Parotid Glands for Head and Neck Cancer Patients during Intensity-modulated Radiotherapy: Effect on the Probability of Xerostomia Incidence
DOI: 10.1016/j.clon.2011.11.006
Abstract: Aims: To quantify the changes in dose as well as in the prediction of parotid gland toxicity due to anatomical changes during therapy of head and neck cancer patients. Materials and methods:...
|
S. Marzi,
P. Pinnarò,
D. D’Alessio,
L. Strigari,
V. Bruzzaniti,
C. Giordano,
G. Giovinazzo,
L. Marucci
et al.
|
Full-length article
(In Press Corrected Proof)
|
06 December 2011 |
|
Clinical Correlations and Prognostic Relevance of Tissue Angiogenic Factors in Patients with Gastric Cancer
DOI: 10.1016/j.clon.2011.11.002
Abstract: Aims: To evaluate the relationship between vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) levels in gastric cancer tissue and clinicopathological features and t...
|
Y. Mohri,
C. Miki,
K. Tanaka,
A. Kawamoto,
M. Ohi,
T. Yokoe,
M. Kusunoki
et al.
|
Full-length article
(In Press Corrected Proof)
|
30 November 2011 |
|
Hypofractionation in Breast Cancer: Is it Fair to Generalise the Data?
DOI: 10.1016/j.clon.2011.11.003
Sir — Recent studies have confirmed the safety and efficacy of hypofractionated radiotherapy in the adjuvant treatment of breast cancer. Appropriate adjustments to the total dose allow 15- or 16-frac...
|
S. Chatterjee,
I. Mallick,
R. Achari
|
Correspondence
(In Press Corrected Proof)
|
28 November 2011 |
|
UK Guidance Document: Treatment of Metastatic Breast Cancer
DOI: 10.1016/j.clon.2011.10.004
Abstract: Although there have been major improvements in the management of breast cancer, with a rapidly falling death rate despite an increasing incidence of the disease, metastatic breast cancer rem...
|
R.E. Coleman,
G. Bertelli,
T. Beaumont,
I. Kunkler,
D. Miles,
P.D. Simmonds,
A.L. Jones,
I.E. Smith
et al.
|
Short communication
(In Press Corrected Proof)
|
10 November 2011 |
|
Concurrent Chemotherapy and Intensity-modulated Radiation Therapy for Anal Carcinoma — Clinical Outcomes in a Large National Cancer Institute-designated Integrated Cancer Centre Network
DOI: 10.1016/j.clon.2011.09.014
Abstract: Aims: To report the clinical outcomes of patients with anal carcinoma treated with intensity-modulated radiation therapy (IMRT) and concurrent chemotherapy in a large integrated academic-com...
|
S.G. DeFoe,
S. Beriwal,
H. Jones,
S. Rakfal,
D.E. Heron,
P. Kabolizadeh,
R.P. Smith,
R. Lalonde
et al.
|
Full-length article
(In Press Corrected Proof)
|
10 November 2011 |
|
The Role of Autophagy in Clinical Practice
DOI: 10.1016/j.clon.2011.09.010
Abstract: Resisting cell death is one of the six hallmarks of cancer. Autophagy is a highly adaptable metabolic process that plays an important role in stressful conditions, such as nutrient deprivati...
|
A.L. Swampillai,
P. Salomoni,
S.C. Short
|
Full-length article
(In Press Corrected Proof)
|
28 October 2011 |
|
Gefitinib Compared with Systemic Chemotherapy as First-line Treatment for Chemotherapy-naive Patients with Advanced Non-small Cell Lung Cancer: A Meta-analysis of Randomised Controlled Trials
DOI: 10.1016/j.clon.2011.09.013
Abstract: To define the efficacy of gefitinib in chemotherapy-naive patients with advanced non-small cell lung cancer, we carried out a meta-analysis of randomised controlled trials. Medline, Embase, ...
|
F. Wang,
L.D. Wang,
B. Li,
Z.X. Sheng
|
Full-length article
(In Press Corrected Proof)
|
24 October 2011 |
|
Single Agent Weekly Paclitaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A Feasibility Study
DOI: 10.1016/j.clon.2011.09.012
Abstract: Aim: To study the toxicity profile and response rates of weekly paclitaxel given as neoadjuvant chemotherapy (NACT) in patients with locally advanced breast cancer. Materials and methods: Th...
|
S. Gupta,
R. Bharath,
T. Shet,
S.B. Desai,
V.M. Patil,
A. Bakshi,
V. Parmar,
R.A. Badwe
et al.
|
Full-length article
(In Press Corrected Proof)
|
20 October 2011 |
|
Expression of HER2neu in Ductal Carcinoma in situ is Associated with Local Recurrence
DOI: 10.1016/j.clon.2011.09.008
Abstract: Aims: Determination of the risk of recurrence after local excision of ductal carcinoma in situ (DCIS) remains a challenge. Molecular profiling based on immunohistochemical staining to oestro...
|
K. Han,
S. Nofech-Mozes,
S. Narod,
W. Hanna,
D. Vesprini,
R. Saskin,
C. Taylor,
I. Kong,
L. Paszat,
E. Rakovitch
et al.
|
Full-length article
(In Press Corrected Proof)
|
28 September 2011 |
|
Accuracy and Completeness of Pathology Reporting — Impact on Partial Breast Irradiation Eligibility
DOI: 10.1016/j.clon.2011.09.004
Abstract: Aims: Accelerated partial breast irradiation (APBI) is an alternative to whole breast irradiation that is delivered over a shorter period of time with less toxicity. Appropriate patient sele...
|
J.-P. Pignol,
E. Rakovitch,
J. Zeppieri,
W. Hanna
|
Full-length article
(In Press Corrected Proof)
|
21 September 2011 |
|
The Management of Neuroendocrine Tumours: Current and Future Medical Therapy Options
DOI: 10.1016/j.clon.2011.08.006
Abstract: Neuroendocrine tumours (NETs) are a genetically diverse group of malignancies that sometimes produce peptides causing characteristic hormonal syndromes. NETs can be clinically symptomatic (f...
|
K.E. Öberg
|
Full-length article
(In Press Corrected Proof)
|
12 September 2011 |
|
Image-guided Radiotherapy for Rectal Cancer — A Systematic Review
DOI: 10.1016/j.clon.2011.07.012
Abstract: Radiotherapy for rectal cancer is becoming more conformal. Both the rectum and the mesorectum are mobile structures and the use of image-guided radiotherapy techniques may improve treatment ...
|
S. Gwynne,
R. Webster,
R. Adams,
S. Mukherjee,
B. Coles,
J. Staffurth
et al.
|
Full-length article
(In Press Corrected Proof)
|
19 August 2011 |
|
Volumetric Modulated Arc Therapy with Simultaneous Integrated Boost for Locally Advanced Rectal Cancer
DOI: 10.1016/j.clon.2011.07.001
Abstract: Aims: To report the feasibility of volumetric modulated arc therapy (VMAT) for neoadjuvant radiotherapy in locally advanced rectal cancer in a dose-escalation protocol and simultaneous integ...
|
S. Cilla,
L. Caravatta,
V. Picardi,
D. Sabatino,
G. Macchia,
C. Digesù,
F. Deodato,
M. Massaccesi,
M. De Spirito,
A. Piermattei,
A.G. Morganti
et al.
|
Full-length article
(In Press Corrected Proof)
|
05 August 2011 |
|
The Concepts, Diagnosis and Management of Early Imaging Changes after Therapy for Glioblastomas
DOI: 10.1016/j.clon.2011.06.004
Abstract: Since postoperative radiotherapy plus concomitant temozolomide followed by adjuvant temozolomide has become standard treatment for glioblastoma, the phenomenon of early post-treatment enlarg...
|
P. Sanghera,
R. Rampling,
B. Haylock,
S. Jefferies,
C. McBain,
J.H. Rees,
C. Soh,
I.R. Whittle
et al.
|
Full-length article
(In Press Corrected Proof)
|
25 July 2011 |
|
Dual Arc Volumetric-modulated Arc Radiotherapy (VMAT) of Nasopharyngeal Carcinomas: A Simultaneous Integrated Boost Treatment Plan Comparison with Intensity-modulated Radiotherapies and Single Arc VMAT
DOI: 10.1016/j.clon.2011.06.006
Abstract: Aims: To compare the performance of volumetric-modulated arc radiotherapy (VMAT) by dual arc with fixed beam intensity-modulated radiotherapies (IMRTs) and single arc VMAT on nasopharyngeal ...
|
T.-F. Lee,
H.-M. Ting,
P.-J. Chao,
F.-M. Fang
|
Full-length article
(In Press Corrected Proof)
|
13 July 2011 |
|
A Dosimetric Planning Study Comparing Intensity-modulated Radiotherapy with Four-field Conformal Pelvic Radiotherapy for the Definitive Treatment of Cervical Carcinoma
DOI: 10.1016/j.clon.2011.06.008
Abstract: Aims: To compare the dose to organs at risk (OAR) between a conventional four-field whole pelvis radiotherapy (4F-WPRT) plan and an initial single intensity-modulated WPRT (IM-WPRT) plan for...
|
J. Forrest,
J. Presutti,
M. Davidson,
P. Hamilton,
A. Kiss,
G. Thomas
et al.
|
Full-length article
(In Press Corrected Proof)
|
13 July 2011 |
|
Methylenetetrahydrofolate Reductase (MTHFR) Gene C677T, A1298C and G1793A Polymorphisms: Association with Risk for Clear Cell Renal Cell Carcinoma and Tumour Behaviour in Men
DOI: 10.1016/j.clon.2011.03.005
Abstract: Aims: Methylenetetrahydrofolate reductase (MTHFR) plays a crucial role in regulating folate metabolism, which affects DNA synthesis and methylation. This study investigated whether MTHFR C67...
|
M.R. Safarinejad,
N. Shafiei,
S. Safarinejad
|
Full-length article
(In Press Corrected Proof)
|
14 April 2011 |
|
Clinical Outcome of Low-risk Differentiated Thyroid Cancer Patients after Radioiodine Remnant Ablation and Recombinant Human Thyroid-stimulating Hormone Preparation
DOI: 10.1016/j.clon.2011.02.011
Abstract: Aim: Recombinant human thyroid-stimulating hormone (rhTSH) has been approved in Europe as a preparation tool for radioiodine ablation of post-surgical thyroid remnants in patients with low-r...
|
F. Vianello,
R. Mazzarotto,
C. Mian,
O. Lora,
G. Saladini,
O. Servodio,
M. Basso,
G. Pennelli,
M.R. Pelizzo,
G. Sotti
et al.
|
Full-length article
(In Press Corrected Proof)
|
16 March 2011 |
|
WITHDRAWN: Recent Advances in Angiopoietin Biology in Cancer — A Review
DOI: 10.1016/j.clon.2011.01.153
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be foun...
|
Suhasini Joshi,
Ashish Tiwari
|
Retraction
(In Press Corrected Proof)
|
09 February 2011 |